NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DermaScan

DermaScan

Private
ParisHealthcare & Life Scienceshttps://www.dermascan.fr/

Last Round

Seed

Feb 2, 2026

Total Funding Raised

$2.96M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DermaScan is a healthcare company that operates expert centers for skin cancer screening, combining clinical examinations, total body mapping, and technological innovations to provide early detection.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Drug Discovery, Medical Devices, Compliance

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract research organizationCROclinical trialscosmetic testingsafety testingefficacy testingclaim substantiationdermo-cosmetic testingin-vivo testingpre-clinical testingin-vitro testingpharmaceutical testingregulatory consultingbiometrologysensory testingmicrobiology testingmedical device testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DermaScan Comps

Public and private peers based on sector, stage, and business model.

DermaScan comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DermaScan Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 2, 2026

Key People

Founding team and executive leadership

Hadrien Lepage

Co-founder CTO

Founding Team

Florian LEGRIS

Co-founder CEO

Founding Team

DermaScan Investors

Notable investors and investment history

DermaScan investors
InvestorRounds
Kima VenturesSeed
HexaSeed
TechmindSeed
Ring CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 25, 2026

    Grew 36% QoQ, from 11 to 15 employees.

  • Apr 15, 2026

    Monthly visitors increased 544% MoM.

DermaScan Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DermaScan Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DermaScan's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range15
Year Founded2025
Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.